Gartner Research

Forecast: Biotechnology Trends, Segmentation and Offerings, North America, 2003-2008

Published: 31 January 2005

ID: G00125616

Analyst(s): Geraldine Cruz


The U.S. biotechnology market will increase its IT spending from $1.4 billion in 2003 to $2 billion in 2008. The highest share of IT investments will be for R&D. Mergers, acquisitions and partnerships are rife as companies pool resources to fund R&D to promote economies of scale.

©2020 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.